CSIMarket
 

Davita Inc   (DVA)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare

Davita Inc 's

Competitiveness


 

DVA Sales vs. its Competitors Q4 2023



Comparing the current results to its competitors, Davita Inc reported Revenue increase in the 4 quarter 2023 by 7.85 % year on year.
The sales growth was above Davita Inc 's competitors' average revenue growth of 2.3 %, achieved in the same quarter.

List of DVA Competitors

With a net margin of 7.33 % Davita Inc achieved higher profitability than its competitors.

More on DVA Profitability Comparisons



Revenue Growth Comparisons




Net Income Comparison


Davita Inc Net Income in the 4 quarter 2023 grew year on year by 82.1%, faster than the Davita Inc 's competitors average income growth of 7.46 %

<<  DVA Stock Performance Comparisons


Davita Inc 's Comment on Competitors and Industry Peers


U.S. and International dialysis competition
The U.S. dialysis industry has consolidated significantly over time but still remains highly competitive, particularly in terms of acquiring existing outpatient dialysis centers. We continue to face a high degree of competition in the U.S. dialysis industry from large and medium-sized providers who compete directly with us for the acquisition of dialysis businesses, relationships with physicians to act as medical directors and for individual patients. In addition, as we continue our international dialysis expansion into various international markets, we will face competition from large and medium-sized providers for these acquisition targets as well. Because of the ease of entry into the dialysis business and the ability of physicians to be medical directors for their own centers, competition for growth in existing and expanding markets is not limited to large competitors with substantial financial resources. Acquisitions, developing new outpatient dialysis centers, patient retention and physician relationships are a critical component of our growth strategy and our business could be adversely affected if we are not able to continue to make acquisitions on reasonable terms, continue to develop new dialysis centers, maintain or establish new relationships with physicians or if we experience significant patient attrition to our competitors. Competition for qualified physicians to act as medical directors and for inpatient dialysis services agreements with hospitals is also intense. Occasionally, we have also experienced competition from former medical directors or referring physicians who have opened their own dialysis centers. In addition, we experience competitive pressures in connection with negotiating contracts with commercial healthcare payors.

The two largest dialysis companies, FMC and our company, account for approximately 71% of outpatient dialysis patients in the U.S. with our company serving approximately 35% of the total outpatient dialysis patients. Approximately 44% of the centers not owned by us or FMC are owned or controlled by hospitals or non-profit organizations. Hospital-based and non-profit dialysis units typically are more difficult to acquire than physician-owned centers.

HCP’s competition
HCP’s business is highly competitive. HCP competes with managed care organizations, hospitals, medical groups and individual physicians in its markets. HCP competes with other primary care physician groups or physicians who contract with health plans for membership. Health plans contract with care providers on the basis of costs, reputation, scope, efficiency and stability. Individual members select a primary care physician at the time of membership with the health plan. Location, name recognition, quality indicators and other factors go into that decision. For example, in California, HCP competes with both Permanente Medical Group, which is the exclusive provider for Kaiser, and Heritage Provider Network. However, HCP’s principal competitors for members and health plan contracts vary by market.
Corporate compliance program
Our businesses are subject to extensive federal, state and local government regulations. Management has designed and implemented a corporate compliance program as part of our commitment to comply fully with all applicable laws and regulations and to maintain the high standards of conduct we expect from all of our teammates. We continuously review this program and enhance it as necessary. The primary purposes of the program include:
Assessing and identifying risks for existing and new businesses, such as HCP;

Increasing, through training and education, the awareness of our teammates and affiliated professionals of the necessity of complying with all applicable laws, regulations and company policies and procedures;

Auditing and monitoring the activities of our operating units and business support functions on a regular basis to identify potential instances of noncompliance in a timely manner; and

Ensuring that we take steps to resolve instances of noncompliance or to address areas of potential noncompliance as promptly as we become aware of them.

We have a code of conduct that each of our teammates and affiliated professionals must follow and we have a confidential toll-free hotline for teammates and patients to report potential instances of noncompliance. Our Chief Compliance Officer administers the compliance program. The Chief Compliance Officer reports directly to our Chief Operating Officer and to the Compliance Committee of our Board of Directors.





  

Overall company Market Share Q4 2023

With revenue growth of 7.85 % within Overall company, Davita Inc achieved improvement in market share, within Overall company to approximately 10.38 %.
<<  More on DVA Market Share.
 
*Market share is calculated based on total revenue.





Who are Davita Inc 's Competitors?




Fresenius Medical Care Ag
Share Performance



-10.40%
This Year



Fresenius Medical Care Ag
Profile

Fresenius Medical Care AG & Co. KGaA is a global healthcare company that specializes in providing services and products for patients with chronic kidney failure. Their business model focuses on offering a comprehensive range of innovative dialysis products, services, and patient care for individuals suffering from kidney-related issues. Through their network of clinics, dialysis centers, and manufacturing sites, they aim to provide high-quality renal care and improve the lives of patients worldwide.

More about Fresenius Medical Care Ag's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 5,586.592 mill. $ 21,788.051 mill. $ 820.353 mill.


Heartland Media Acquisition Corp
Share Performance



+3.64%
This Year



Heartland Media Acquisition Corp
Profile

Heartland Media Acquisition Corp operates as a blank check company seeking to merge or acquire one or more businesses or assets in the media and entertainment sectors, with a focus on broadcast television stations and other digital media platforms. Its business model involves raising funds through an initial public offering (IPO) and utilizing the proceeds to identify potential targets for acquisitions or partnerships within the media industry.

More about Heartland Media Acquisition Corp 's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 202.863 mill. $ - mill. $ 4.008 mill.


Tenet Healthcare Corp
Share Performance



+0.42%
Over The Past 5 Days



Tenet Healthcare Corp
Profile

Tenet Healthcare Corp operates as a healthcare services company that primarily focuses on managing and providing healthcare facilities, including hospitals, outpatient centers, and physician practices. Their business model revolves around delivering high-quality patient care, optimizing operational efficiency, and maintaining strong physician relationships. They aim to provide comprehensive healthcare services to diverse communities, utilizing advanced medical technology and a multispecialty approach to address the healthcare needs of individuals.

More about Tenet Healthcare Corp's Market Share

Market Cap. Revenues TTM Net Income TTM
$ 10,741.187 mill. $ 20,548.000 mill. $ 1,311.000 mill.



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com